SynthesisFrontiers in oncology2020

Efficacy and Prognostic Factors for PARP Inhibitors in Patients With Ovarian Cancer.

Xuan-Zhang Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.